New app aims to ease mental struggles after ICU stays
NCT ID NCT06504979
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a digital platform called ICURA to help ICU survivors and their families manage emotional, cognitive, and physical problems that often occur after intensive care. About 360 adults who were in the ICU will be randomly assigned to use the app or receive standard follow-up care. The goal is to see if the app improves quality of life and daily functioning over 12 months.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
digital telehealth platform (ICURA)
What this could lead to
If successful, this could provide a practical, scalable way to improve mental health and daily functioning for ICU survivors and their families during the first year after discharge.
What could go wrong
This is an observational study, not a treatment trial, so it cannot prove cause and effect. The digital tool may not work for everyone, and results may vary based on individual circumstances.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POST INTENSIVE CARE SYNDROME are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Institut d'Investigació i Innovació Parc Taulí
Sabadell, Barcelona, 08208, Spain